Sunshield Chemicals has informed that the Board of Directors of the Company at its meeting held today i.e. on 13th May 2026, approved the Audited financial results for the quarter and year ended 31st March 2026 and Auditors Report issued by CNK & Associates LLP, Statutory Auditor of the Company are enclosed. Pursuant to Regulation 33(3)(d) the Statutory Auditors of the Company have issued Audit Report with 'Unmodified Opinion' on the Audited Financial Results of the Company for the year ended 31st March 2026; Recommended payment of final dividend @ Rs 3 per equity share of the face value of Rs 10 each for the financial year ended 31st March 2026, subject to approval of shareholders at the ensuing 39th Annual General Meeting (AGM); Based on recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved reappointment of Cyrus Poonevala (DIN: 09420865) as an Independent Director for the second term of five years effective from 15th January 2027 subject to approval of the Members at the ensuing AGM. The details in respect of the above re-appointments of Directors, as required under SEBI Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 are enclosed as Annexure A. The Board Meeting started at 11.30 am and concluded at 12.55 pm.
The above information is a part of company’s filings submitted to BSE.
